Congratulations to Dr. Barton Haynes, director of the DHVI.
In laboratory and primate tests, a new pan-coronavirus vaccine developed by the Duke Human Vaccine Institute has demonstrated wide protection against SARS-CoV-2 viruses and variants, including Omic
Duke Human Vaccine Institute researchers are featured on the PBS NC series SCI NC and explain the work that goes into creating a vaccine that can protect us against all potential coronaviruses.
A rare type of antibody found in some individuals could help develop an HIV vaccine to target highly diverse viral strains.
Kevin Saunders explains the technology he used when COVID-19 hit, “We thought of creating a vaccine with properties that the current vaccines lacked.”